APA (7th ed.) Citation

Lin, L., Wen, J., Xu, T., & Si, Y. (2024). TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway. Cancer Biology & Therapy, 25(1), 1. https://doi.org/10.1080/15384047.2024.2424570

Chicago Style (17th ed.) Citation

Lin, Lizhi, Jialiang Wen, Tiansheng Xu, and Yuhao Si. "TM4SF4 Is a Diagnostic Biomarker Accelerating Progression of Papillary Thyroid Cancer via AKT Pathway." Cancer Biology & Therapy 25, no. 1 (2024): 1. https://doi.org/10.1080/15384047.2024.2424570.

MLA (9th ed.) Citation

Lin, Lizhi, et al. "TM4SF4 Is a Diagnostic Biomarker Accelerating Progression of Papillary Thyroid Cancer via AKT Pathway." Cancer Biology & Therapy, vol. 25, no. 1, 2024, p. 1, https://doi.org/10.1080/15384047.2024.2424570.